Your source for technology insights, tutorials, and guides.
Linux 7.2 kernel will change default DRM scheduler to 'Fair' priority and add support for AMD's AIE4 accelerator via AMDXDNA driver, improving GPU fairness and AI capabilities.
Step-by-step guide to the Motorola Razr Fold's book-style design, Snapdragon 8 Gen 5, 16GB RAM, 6000mAh battery, and 80W charging. Includes prerequisites and tips.
Mesa developers propose moving older GPU drivers (AMD R300/R600) to a legacy branch to modernize codebase, impacting legacy support but boosting modern graphics performance.
Anbernic's upcoming RG Rotate handheld features a flip-out square display, nostalgic design, and affordable price starting at $88. Learn more here.
Intel's Linux 7.2 driver overhaul for Crescent Island Xe3P GPU boosts inference performance by 15-20%. The 160GB vRAM accelerator targets AI enterprise workloads, with open-source updates now live.
Discover 7 key features of the Volla Phone Plinius: dual OS choice, privacy-first Volla OS, Ubuntu Touch, rugged IP68 design, 120Hz OLED display, mid-range MediaTek chip, and long-term updates.
ASUS ROG RAIKIRI II controller receives native Linux support, closing a major gap for open-source gamers. Mainline kernel driver incoming.
Wildfire smoke poses a growing health threat, with data showing increased respiratory, cardiovascular, and economic impacts, especially for vulnerable populations.
AstraZeneca resumes $400M UK R&D after trade deal; Supreme Court hears 'skinny labeling' case involving Amarin and Hikma, impacting generic drug patents.
Senate Minority Leader Chuck Schumer outlines Democratic principles to lower health care costs across drug prices, insurance premiums, and out-of-pocket spending, signaling a major policy push for 2024.
Cigna announces exit from ACA individual markets by 2027, affecting 369,000 members. Strategic refocus on Evernorth and employer plans. Impacts market stability.
Hinge's new FDA-cleared migraine device offers non-invasive neuromodulation for acute pain relief. This portable TENS-based gadget targets trigeminal nerves, providing a drug-free alternative.
DOJ blocked from deposing Elevance Health executive in Medicare Advantage fraud case; dispute over timing of departure raises stakes in $40B lawsuit.
New preclinical obesity drug combines five mechanisms in mice; NIH funding crisis; Novartis reshoring; Alzheimer's program halted; other pharma news.
FDA moves to exclude semaglutide and tirzepatide from bulk compounding list, impacting access to cheaper weight loss drugs.
Trump replaces Casey Means with Nicole Saphier for Surgeon General, mixing MAHA wellness with conventional medicine skepticism.
A new Science study shows AI beating doctors in diagnostic tests, but researchers warn against misusing simulated results as proof of safety for real patients. Cautious optimism is needed.
Explore biotech innovations in hair loss treatments, AI in clinical trials, and nonprofit M&A strategies, featuring insights from Veradermics and Servier.
Nicole Saphier, the new surgeon general nominee, brings medical credentials and a nuanced stance on vaccines and the MAHA movement, balancing enthusiasm for reform with evidence-based caution.
Katherine Szarama named acting director of FDA's CBER, replacing Vinay Prasad after his controversial tenure. CBER oversees vaccines, gene therapies, and blood supply.